Michel Rives

754 total citations
17 papers, 244 citations indexed

About

Michel Rives is a scholar working on Surgery, Otorhinolaryngology and Radiation. According to data from OpenAlex, Michel Rives has authored 17 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Otorhinolaryngology and 7 papers in Radiation. Recurrent topics in Michel Rives's work include Head and Neck Cancer Studies (9 papers), Advanced Radiotherapy Techniques (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). Michel Rives is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Advanced Radiotherapy Techniques (7 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). Michel Rives collaborates with scholars based in France, Switzerland and Egypt. Michel Rives's co-authors include Thomas Filleron, S. Vergèz, Anne Laprie, Jacques Bonnet, M. Delannes, M. Alfonsi, A. Modesto, P. Gräff, L. Vieillevigne and Yungan Tao and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and The Journal of Pediatrics.

In The Last Decade

Michel Rives

17 papers receiving 242 citations

Peers

Michel Rives

SURGE

ONCOL

OTORH

PRM

RADIA

Madhup Rastogi India

Nadia Bulzonetti Italy

Matteo Augugliaro Italy

Rodger M. Pryzant United States

J. Mengual Spain

A. Millà Spain

A. Rijnders Belgium

Jacek Skoczylas Poland

Víctor A. Marcial-Vega United States

Mina Yu South Korea

Madhup Rastogi India

Michel Rives

53 ×0.5

SURGE

72 ×0.7

ONCOL

75 ×0.8

OTORH

101 ×1.5

PRM

18 ×0.3

RADIA

Citations per year, relative to Michel Rives Michel Rives (= 1×) peers Madhup Rastogi

Countries citing papers authored by Michel Rives

Since Specialization

Citations

This map shows the geographic impact of Michel Rives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Rives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Rives more than expected).

Fields of papers citing papers by Michel Rives

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Rives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Rives. The network helps show where Michel Rives may publish in the future.

Co-authorship network of co-authors of Michel Rives

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Rives. A scholar is included among the top collaborators of Michel Rives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Rives. Michel Rives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lusque, Amélie, P. Gräff, A. Modesto, et al.. (2019). The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer. Clinical and Translational Radiation Oncology. 16. 34–39. 4 indexed citations

Modesto, A., Amélie Lusque, Jean‐Pierre Delord, et al.. (2019). Definitive radiochemotherapy or initial surgery for oropharyngeal cancer. Strahlentherapie und Onkologie. 195(6). 496–503. 10 indexed citations

Sun, Xu, Christian Sire, Yungan Tao, et al.. (2018). A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.. Journal of Clinical Oncology. 36(15_suppl). 6018–6018. 42 indexed citations

Bibault, Jean‐Emmanuel, Sophie Dussart, P. Pommier, et al.. (2017). Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(4). 929–937. 20 indexed citations

Tao, Yungan, Anne Aupérin, P. Gräff, et al.. (2017). Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. Oral Oncology. 71. 61–66. 10 indexed citations

Rives, Michel, et al.. (2017). Dose to organ at risk and dose prescription in liver SBRT. Reports of Practical Oncology & Radiotherapy. 22(2). 96–102. 12 indexed citations

Bourhis, Jean, Anne Aupérin, M. Alfonsi, et al.. (2017). Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial.. Journal of Clinical Oncology. 35(15_suppl). 6015–6015. 6 indexed citations

Perrier, Lionel, P. Pommier, Pierre Boisselier, et al.. (2016). Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 95(2). 654–662. 11 indexed citations

Vieillevigne, L., et al.. (2015). Is dose escalation achievable for esophageal carcinoma?. Reports of Practical Oncology & Radiotherapy. 20(2). 135–140. 8 indexed citations

10.

Khalifa, Jonathan, L. Vieillevigne, M. Ouali, et al.. (2014). Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment. Radiation Oncology. 9(1). 247–247. 6 indexed citations

11.

Modesto, A., Anne Laprie, L. Vieillevigne, et al.. (2014). Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer. Strahlentherapie und Onkologie. 191(3). 225–233. 15 indexed citations

12.

Rives, Michel, et al.. (2013). Cystadenocarcinoma of the parotid: case report of a BRAF inhibitor treatment. SpringerPlus. 2(1). 679–679. 5 indexed citations

13.

Thariat, Juliette, Pierre‐Olivier Védrine, Stéphane Temam, et al.. (2012). The Role of Radiation Therapy in Pediatric Mucoepidermoid Carcinomas of the Salivary Glands. The Journal of Pediatrics. 162(4). 839–843. 32 indexed citations

14.

Ducassou, Anne, et al.. (2011). Retrospective Analysis of Local Control and Cosmetic Outcome of 147 Periorificial Carcinomas of the Face Treated With Low–Dose Rate Interstitial Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 81(3). 726–731. 13 indexed citations

15.

Vergèz, S., et al.. (2010). Brachytherapy in Lip Carcinoma: Long-Term Results. International Journal of Radiation Oncology*Biology*Physics. 81(5). e839–e843. 27 indexed citations

16.

Courbon, F., Thomas Filleron, Michel Rives, et al.. (2010). Coregistration of Prechemotherapy PET-CT for Planning Pediatric Hodgkin's Disease Radiotherapy Significantly Diminishes Interobserver Variability of Clinical Target Volume Definition. International Journal of Radiation Oncology*Biology*Physics. 80(3). 793–799. 20 indexed citations

17.

Astudillo, L., et al.. (2004). Stevens–Johnson syndrome after amifostine during radiotherapy. International Journal of Dermatology. 43(4). 284–285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact